Jagannath Chemical And Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 11-12-2024
- Paid Up Capital ₹ 3.48 M
as on 11-12-2024
- Company Age 64 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.87 Cr
as on 11-12-2024
- Satisfied Charges ₹ 2.86 Cr
as on 11-12-2024
- Revenue 160.63%
(FY 2019)
- Profit 284.86%
(FY 2019)
- Ebitda 22.04%
(FY 2019)
- Net Worth 13.57%
(FY 2019)
- Total Assets 55.12%
(FY 2019)
About Jagannath Chemical And Pharmaceutical Works
The Corporate was formerly known as Jagannath Chemical And Pharmaceutical Works Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.48 M.
The company currently has active open charges totaling ₹12.87 Cr. The company has closed loans amounting to ₹2.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pinky Modi and Rajesh Modi serve as directors at the Company.
- CIN/LLPIN
U24231OR1960PTC000391
- Company No.
000391
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 1960
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jagannath Chemical And Pharmaceutical Works?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Modi  | Managing Director | 03-Aug-2011 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pinky Modi | Director | 10-Aug-2012 | Current |
Financial Performance of Jagannath Chemical And Pharmaceutical Works.
Jagannath Chemical And Pharmaceutical Works Pvt Ltd, for the financial year ended 2019, experienced significant growth in revenue, with a 160.63% increase. The company also saw a substantial improvement in profitability, with a 284.86% increase in profit. The company's net worth Soared by an impressive increase of 13.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagannath Chemical And Pharmaceutical Works?
In 2019, Jagannath Chemical And Pharmaceutical Works had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 28 Nov 2024 | ₹1.50 Cr | Open |
Others Creation Date: 27 Aug 2024 | ₹4.90 Cr | Open |
Sidbi Creation Date: 08 Nov 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Jagannath Chemical And Pharmaceutical Works?
Unlock and access historical data on people associated with Jagannath Chemical And Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagannath Chemical And Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagannath Chemical And Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
